In the first week of May, India’s health ministry convened a video call with the country’s drug makers. As cases of the novel coronavirus continued to mount, the government wanted to know wanted to know The Print Govt asks pharma firms when remdesivir, the big hope against Covid, can be made in India Read more  how they planned to bring remdesivir to India. 

An antiviral drug manufactured by pharma major Gilead Sciences, the US drug regulator had recently authorised the emergency use of remdesivir for the treatment of Covid-19 patients.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Sign up to our India edition to read this story instantly

To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of 214+ previously published free stories from our India edition. You’ll also receive one email every morning from us introducing the day’s story.

If you’ve already signed up, just enter your email below or login using Facebook or Google.